EPCAM and cancer: Captured CTCs will then be used to profile expression of cancer-specific membrane proteins such as EpCAM, cytokeratin (CK), vimentin, and CD133, where the latter two markers used to identify mesenchymal and stem cells phenotypes [110–112].